Boxer Capital, LLC - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28,272,000
+96715.3%
2,325,0000.0%1.50%
+11.2%
Q2 2023$29,202
+13.3%
2,325,0000.0%1.35%
+6.9%
Q1 2023$25,784
-99.9%
2,325,0000.0%1.27%
-15.4%
Q4 2022$28,388,250
+17.0%
2,325,0000.0%1.50%
+9.7%
Q3 2022$24,273,000
-2.8%
2,325,0000.0%1.36%
-13.7%
Q2 2022$24,971,000
+13.4%
2,325,0000.0%1.58%
+39.8%
Q1 2022$22,018,000
-18.0%
2,325,0000.0%1.13%
+8.5%
Q4 2021$26,854,000
+20.9%
2,325,0000.0%1.04%
+34.6%
Q3 2021$22,204,000
-0.9%
2,325,0000.0%0.78%
-2.0%
Q2 2021$22,413,000
-2.4%
2,325,0000.0%0.79%
+1.5%
Q1 2021$22,971,000
-57.2%
2,325,0000.0%0.78%
-54.9%
Q4 2020$53,684,000
+63.5%
2,325,0000.0%1.73%
+52.2%
Q3 2020$32,829,000
-6.4%
2,325,0000.0%1.13%
-26.4%
Q2 2020$35,061,000
+63.2%
2,325,0000.0%1.54%
+5.3%
Q1 2020$21,483,000
-5.1%
2,325,0000.0%1.46%
+14.3%
Q4 2019$22,646,000
+21.4%
2,325,0000.0%1.28%
-5.3%
Q3 2019$18,647,000
-35.7%
2,325,0000.0%1.35%
-45.8%
Q2 2019$29,016,0002,325,0002.50%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,524,022$127,972,10812.11%
Perceptive Advisors 27,692,917$336,745,87011.23%
Redmile Group, LLC 16,944,621$206,046,5919.80%
Finepoint Capital LP 1,489,025$18,106,5449.02%
CM Management, LLC 450,000$5,472,0005.81%
Avoro Capital Advisors LLC 27,400,000$333,184,0005.20%
MPM BioImpact LLC 716,139$8,708,2502.32%
Artal Group S.A. 4,062,567$49,4012.12%
SECTORAL ASSET MANAGEMENT INC 803,464$9,770,1221.90%
GREAT POINT PARTNERS LLC 857,000$10,421,1201.90%
View complete list of AMICUS THERAPEUTICS INC shareholders